Day: May 15, 2024

CORAL GABLES, Fla., May 15, 2024 (GLOBE NEWSWIRE) — MSP Recovery, Inc. d/b/a LifeWallet (NASDAQ: LIFW) (“LifeWallet,” or the “Company”), a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery and technology leader, today announced financial results for the quarter ended March 31, 2024. LifeWallet will host a conference call and live webcast to review the Company’s first quarter 2024 results for investors and analysts at 8:30 a.m. Eastern Time on Thursday, May 16, 2024. To access this call, we encourage you to pre-register using this link: LifeWallet Q1 2024 Earnings Pre-Registration. A live webcast of the conference call will be accessible from the Investors section of LifeWallet’s website here: LifeWallet Investors. A replay of the webcast will be archived and accessible here: LifeWallet...

Revenue grew 24% year-over-year, or 29% on a constant currency basis to $653 million On-Demand GMV grew 18% year-over-year, or 21% on a constant currency basis to $4.2 billion Operating Loss improved by $129 million year-over-year to $(75) million Adjusted EBITDA improved by $129 million year-over-year to an all-time high of $62 million 2024 Adjusted EBITDA guidance raised to $250 – $270 million from $180 – $200 million previously SINGAPORE, May 16, 2024 (GLOBE NEWSWIRE) — Grab Holdings Limited (NASDAQ: GRAB) today announced unaudited financial results for the first quarter ended March 31, 2024. “Our focus on product-led growth is bearing fruit, with On-Demand GMV scaling to new highs in spite of the seasonal impact we usually see in the first quarter of the year. Our push on affordability and reliability is pulling more people...

Last patient last visit in randomized, double-blind, SIGNAL-AD Phase 2a study of pepinemab treatment for Alzheimer’s Disease is scheduled for early June 2024 ROCHESTER, N.Y., May 15, 2024 (GLOBE NEWSWIRE) — Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating neurodegenerative disease and cancer through the inhibition of Semaphorin 4D (SEMA4D), today announced financial results for the first quarter ended March 31, 2024, and provided a corporate update on its key program for Alzheimer’s disease. Treatment with pepinemab believed to halt or slow progression of neurodegenerative disease: Vaccinex expects to complete the planned 12-months of treatment of the last patients enrolled in its randomized, double-blind, Phase 2a SIGNAL-AD trial of pepinemab anti-SEMA4D antibody...

SHANGHAI, China, May 15, 2024 (GLOBE NEWSWIRE) — Dada Nexus Limited (NASDAQ: DADA, “Dada”, the “Company”, or “we”), China’s leading local on-demand retail and delivery platform, today announced its unaudited financial results for the first quarter ended March 31, 2024. “We are pleased to announce that our on-demand retail service has been upgraded to JD NOW, aiming to bring quality goods to consumers at top-notch speeds. With the introduction of the new brand, we have entered a new chapter with a focus on building a sustainable ecosystem,” said Mr. Bing Fu, Interim President of Dada, “For JD NOW, we are determined to fully embrace the JD.com ecosystem in a customer-centric approach and are making dedicated investments to improve customer experience, including rolling out delivery fee waiver program and further lowering the free...

VANCOUVER, British Columbia, May 15, 2024 (GLOBE NEWSWIRE) — Euro Manganese Inc. (TSX-V and ASX: EMN; OTCQB: EUMNF; Frankfurt: E06) (the “Company” or “EMN”) today announced financial results and key developments during the second fiscal quarter and to date. The Company has now filed its March 31, 2024, second fiscal quarter Financial Statements and Management’s Discussion and Analysis. Euro Manganese’s fiscal year end is September 30. Key Developments During and Subsequent to the Quarter Chvaletice Project, Czech Republic Chvaletice Manganese Project (“Chvaletice Project” or the “Project”) was formally listed as under appraisal for debt financing with the European Investment Bank (“EIB”). Funding from the EIB would complement a broader funding package to support the...

SEATTLE, May 15, 2024 (GLOBE NEWSWIRE) — Banzai International, Inc. (NASDAQ: BNZI) (“Banzai” or the “Company”), a leading SaaS marketing technology company, today reported financial results for the first quarter ended March 31, 2024. First Quarter 2024 Financial Summary and Recent Operational Highlights Annual Recurring Revenue (“ARR”) for March 2024 was $4.9 million, a 14.2% increase compared to Q4 2023, and a 5% increase year-over-year. Revenue of $1.1 million exceeded the operating forecast as of the previous quarter by 4%. Net Income increased sequentially by $1.9 million, a 30% increase from Q4 2023. The Company added over 230 customers in April, bringing the total number of customer wins and reactivations during the first four months of 2024 to 810. Banzai unveiled Reach 2.0, a major milestone release of the Company’s flagship...

First Quarter 2024 vs. First Quarter 2023 Revenue of $19.1 million compared to $22.0 million; Gross profit of $3.6 million compared to $4.7 million; Gross profit margin of 18.6% compared to 21.2%; Net income of $0.2 million compared to $1.0 million; Earnings per share of $0.01 compared to $0.08; Cash flow used in operations of ($1.0) million compared to $0.9 million provided by cash flow from operations; Debt as of March 31, 2024 of $19.1 million compared to $22.1 million as of March 31, 2023. EDGEWOOD, N.Y., May 15, 2024 (GLOBE NEWSWIRE) — CPI Aerostructures, Inc. (“CPI Aero” or the “Company”) (NYSE American: CVU) today announced financial results for the three month period ended March 31, 2024. “As anticipated, our first quarter 2024 revenue was 13% lower than first quarter 2023, driven primarily by the completion of deliveries...

First Quarter Highlights Revenue of $258.8 million, down 5.4% year-over-year Gross margin of 22.0%, up 1.1% year-over-year Interest expense of $21.1M, down 52.3% year-over-year SG&A of $40.9M, down 7.9% year-over-year Operating profit of $0.1M versus a loss of $6.9 million year-over year Net loss of $25.6 million ($24.9 million attributable to Exela Technologies Inc), an improvement of $19.9 million year-over-year Adjusted EBITDA of $12.9M, down 11.1% year-over-year IRVING, Texas, May 15, 2024 (GLOBE NEWSWIRE) — Exela Technologies, Inc. (“Exela” or the “Company”) (NASDAQ: XELA, XELAP), a global business process automation (“BPA”) leader, announced today its financial results for the first quarter 2024. “Our results show improvement across many operating metrics. We see benefits from increasing operating leverage and plan...